Factors linked to C difficile infection in patients with IBD include IBD activity prior to infection, shorter disease ...

Up to 40% of patients with inflammatory bowel disease (IBD) experience extraintestinal manifestations (EIMs), with the ...

A large-scale analysis has revealed independently validated gut biomarkers that can distinguish patients with inflammatory ...

A ginger compound, furanodienone (FDN), has been found to reduce inflammation and repair gut damage in IBD patients by ...

Better cardiovascular safety and lower risk of all-cause mortality was observed among older adult patients with IBD who received ustekinumab vs vedolizumab.

June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that 'switches' that modify DNA in gut cells play an ... Major Cause of Inflammatory ...

In ulcerative colitis, duvakitug led to clinical remission in up to 48% of patients, with placebo-adjusted rates of 27% at the highest dose. In Crohn's disease, duvakitug achieved endoscopic ...

TAK1 is a key mediator of human inflammatory bowel diseases (IBD) through the NF-kB pathway. Here, the authors show that TAK1 phosphorylates TRADD, which cooperates with RIPK1 to intestinal ...

Scientists at the Icahn School of Medicine at Mount Sinai have uncovered a surprising genetic connection between two very ...

Driven primarily from an increased understanding of the role that inflammation plays in the onset and progression of a number ...